HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterization
- 31 December 1994
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 25 (3-4), 215-233
- https://doi.org/10.1016/0166-3542(94)90005-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antiviral Properties of the HIV-1 Proteinase Inhibitor RO 31-8959Antiviral Chemistry and Chemotherapy, 1994
- CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activityAntimicrobial Agents and Chemotherapy, 1993
- Crystal structures of HIV-1 protease-inhibitor complexesPerspectives in Drug Discovery and Design, 1993
- The HIV-1 Protease as a Therapeutic Target for AIDSAIDS Research and Human Retroviruses, 1992
- Purification, Assay and Kinetic Features of HIV-1 ProteinaseBiological Chemistry Hoppe-Seyler, 1990
- A second front against AIDSNature, 1989
- Distinct biological and serological properties of human immunodeficiency viruses from the brainAnnals of Neurology, 1988
- Cytokine-Induced Expression of HIV-1 in a Chronically Infected Promonocyte Cell LineScience, 1987
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986
- Tight-binding inhibitors—II: Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycinBiochemical Pharmacology, 1975